Resmed

It hasn’t been a great year for the healthcare sector, whether due to company-specific issues or the pressure of a strong Aussie dollar holding back what are predominantly overseas profits. Overall, the healthcare index is up 9.7 per cent for the year, but that’s a far cry from the rest of the market. The S&P/ASX…

2020 was a watershed year for biotech companies around the world. The combination of urgent need, commitment and massive government support saw the huge benefits of research and development on show, when not one but multiple companies produced vaccines for the Coronavirus. Extensive coverage of the sector generated huge enthusiasm for it, with many stocks…